DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Roche - 1 Patterson Belknap Webb - 1 Tyler - 1 Dileep Kumar Yadav - 1 Abhishek Jain - 1 Ratnakar Sharma - 1 Atikur Rahman - 1
Top related locs:
Brooklyn New York U.S United States India New York City
Top related orgs:
Roche Diabetes Care Inc - 1 Amazon - 1 CNBC - 1 Roche Diabetes Care GmbH - 1 Hoffmann - 1 Roche Inc - 1 New - 1 JMD Enterprises - 1

Search resuls for: "Abhishek Jain"


3 mentions found


☆ Roche alleges counterfeit diabetes medical devices were sold on Amazon
  + stars: | 2024-06-10 | by ( Scott Zamost | ) www.cnbc.com   time to read: +4 min
Roche Diabetes Care Inc. Accu-Chek brand glucose test strips are arranged for a photograph in the Brooklyn borough of New York, U.S., on Thursday, April 4, 2019. Roche , one of the world's largest biotech companies, said "dangerous counterfeits" of its diabetes medical devices ended up for sale on Amazon to be bought by patients throughout the United States. "Patients know that Roche's Accu-Chek medical devices are safe, sterile and accurate," the complaint said. After the suit was filed, a judge granted Roche's request for a temporary restraining order to stop the defendants from selling the counterfeit products. The complaint was filed on behalf of Roche Diabetes Care Inc., Roche Diabetes Care GmbH and Hoffmann-La Roche Inc, by attorneys with the New York-based law firm Patterson Belknap Webb & Tyler.
Persons: Roche, Patterson Belknap Webb, Tyler, Dileep Kumar Yadav, Abhishek Jain, Ratnakar Sharma, Atikur Rahman Organizations: Roche Diabetes Care Inc, Amazon, CNBC, Roche Diabetes Care GmbH, Hoffmann, Roche Inc, New, JMD Enterprises, JMD, JMD International Locations: Brooklyn, New York, U.S, United States, India, New York City
☆ Adani Group's problems are 'largely a liquidity-driven issue,' analyst says
  + stars: | 2023-02-28 | by ( ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailAdani Group's problems are 'largely a liquidity-driven issue,' analyst saysAbhishek Jain of Arihant Capital says Adani's "fundamentals won't run" in the short term.
☆ India Budget 2023: Here's what the experts say
  + stars: | 2023-02-01 | by ( ) www.reuters.com   time to read: +13 min
"This budget, therefore, has rewritten the rules for financilisation of savings in India, which will induce expenditures rather incentivise savings. LAKSHMI IYER, CEO-INVESTMENT ADVISORY, KOTAK INVESTMENT ADVISORS LTD"India budget 2023 has offered a multi-dimensional view. The 3 Cs which stand out are - Capex increase - consumption boost - capital gains tax status quo. Additionally, the budget has provided significant direct tax benefits to individuals which will help increase disposable income and support spending. The budget keeps in mind the needs of future India while focusing on Artificial Intelligence and machine learning.
0 next >>
Total: 3